Stock photos, 360° images, vectors and videos
Filters
Quick filters:
Page 1 of 19
RF2HDHHW5–COVID-19 . Structure of corona virus . Spike glycoprotein and envelope protein and membrane protein . Fine detailed texture . Black and white color .
RF2H9EDMH–Virus variant, coronavirus, spike protein. Omicron. Covid-19 seen under the microscope. SARS-CoV-2, 3d rendering
RM2D4R71M–3D print of a spike protein on the surface of SARS-CoV-2—also known as 2019-nCoV, the virus that causes COVID-19, spike proteins cover the surface of
RM2KWGFT2–London, UK. 30th Nov, 2022. Museum staff pose with a visual presentation of the long genetic code of the virus, with the pink part representing the spike protein. Injecting Hope: The race for a COVID-19 vaccine explores the worldwide effort to develop vaccines at pandemic speed in a free exhibition at the Science Museum. It aims to make the invisible visible, from examining the virus itself to revealing the work that made the vaccines possible. Credit: Imageplotter/Alamy Live News
RF2HKPKF6–Image of microscope close-up 3D concept rendering of COVID-19 Spike protein with Virus inside. Coronavirus Alfa, Beta, Gamma and Omicron variants
RM2B2W6KF–Model of a coronavirus Spike Protein on a computer screen as United States President Donald J. Trump tours the Viral Pathogenesis Laboratory at National Institutes of Health ñ Vaccine Research Center in Bethesda, Maryland on March 3, 2020. Credit: Yuri Gripas/Pool via CNP /MediaPunch
RM2GF7NT4–An enlarged 3D model of a spike protein (blue) connected to an antibody (red) sits on a table in VIB-UGent Center, amid the coronavirus disease (COVID-19) pandemic, in Ghent, Belgium August 23, 2021. REUTERS/Bart Biesemans
RM2B2W0GM–Model of a coronavirus Spike Protein on a computer screen as United States President Donald J. Trump tours the Viral Pathogenesis Laboratory at National Institutes of Health ñ Vaccine Research Center in Bethesda, Maryland on March 3, 2020. Credit: Yuri Gripas/Pool via CNP | usage worldwide
RM2KWGD7X–London, UK. 30 Nov 2022. Genetic code for the virus that causes COVID-19, highlighted in pink is the sequence responsible for producing the spike protein - Injecting Hope: The race for a COVID-19 vaccine, a new exhibition at the Science Museum. It explores the worldwide effort to develop vaccines. It aims make the invisible visible: from examining the virus itself to revealing the work that made the vaccines possible. Including pieces by artists Angela Palmer and Junko Mori which help visitors to visualise the virus. Over 100 objects illustrate the response to curb its impact. Credit: Guy Bell
RF2E9DE7M–Spike protein based vaccine for covid-19 or coronavirus protection. Illustration of spike protein vaccine in syringe injecting into a man.
RM2F1FTG7–Varese, Italy. 08th Mar, 2021. Varese, Italy ASST Sette Laghi Research procedure in the microbiology laboratory led by Prof. Fabrizio Maggi and his team during the reconstruction of the new virus genome with the sequencing of the entire instrumental of the entire spike protein, the part of the Sars CoV- 2 In the photo: Prof. Fabrizio Maggi Credit: Independent Photo Agency/Alamy Live News
RM2KWJ3FG–London, England. 30.12.22. Genetic code for the virus that causes COVID-19, highlighted in pink is the sequence responsible for producing the spike protein at Injecting Hope: The race for a COVID-19 vaccine at the Science Museum. Injecting Hope opens today and explores the worldwide effort to develop vaccines at pandemic speed. Credit: SMP News / Alamy Live News
RM2DAF1K2–Kawasaki, Japan. 12th Nov, 2020. This picture shows the headquarters of Japanese drug design venture PeptiDream in Kawasaki, suburban Tokyo on Thursday, November 12, 2020. PeptiDream announces the company will form a joint venture PeptiAID with four companies to development of the new drug for the treatment of COVID-19. PeptiDream developed PDPS technology to find peptide candidates targeting spike protein of coronavirus to enter human cells. PeptiAID will obtain PeptiDream's COVID-19 candidate compounds to enter clinical testing. Credit: Yoshio Tsunoda/AFLO/Alamy Live News
RF2HDHJ0E–COVID-19 . Structure of corona virus . Spike glycoprotein and envelope protein and membrane protein . Fine detailed texture . Black and white color .
RF2H9DJNT–Virus variant, coronavirus, spike protein. Omicron. Covid-19 seen under the microscope. SARS-CoV-2, 3d rendering
RM2D4R721–3D print of a spike protein on the surface of SARS-CoV-2—also known as 2019-nCoV, the virus that causes COVID-19, spike proteins cover the surface of
RM2KWGFP5–London, UK. 30th Nov, 2022. Museum staff pose with a visual presentation of the long genetic code of the virus, with the pink part representing the spike protein. Injecting Hope: The race for a COVID-19 vaccine explores the worldwide effort to develop vaccines at pandemic speed in a free exhibition at the Science Museum. It aims to make the invisible visible, from examining the virus itself to revealing the work that made the vaccines possible. Credit: Imageplotter/Alamy Live News
RF2FMNFER–Corona virus symbolized by protective ffp2 face mask and rapid antigen self test kits as spike proteins placed on white background
RM2GF7NT1–Dr. Xavier Saelens (VIB-UGent Center for Medical Biotechnology group leader) shows an enlarged 3D model of a spike protein (blue) connected to an antibody (red), amid the coronavirus disease (COVID-19) pandemic, in Ghent, Belgium August 23, 2021. REUTERS/ Bart Biesemans
RM2HTJ5A3–Bielefeld, Germany. 28th Feb, 2022. View of the entrance to the Bielefeld vaccination center. The corona vaccine Nuvaxovid (NVX-CoV2373) from the US manufacturer Novavax has been vaccinated in Germany for a short time. Nuvaxovid is a so-called protein vaccine. It contains coronavirus-like particles with the corona protein 'spike protein'. Credit: Friso Gentsch/dpa/Alamy Live News
RM2KWGC65–London, UK. 30 Nov 2022. Genetic code for the virus that causes COVID-19, highlighted in pink is the sequence responsible for producing the spike protein - Injecting Hope: The race for a COVID-19 vaccine, a new exhibition at the Science Museum. It explores the worldwide effort to develop vaccines. It aims make the invisible visible: from examining the virus itself to revealing the work that made the vaccines possible. Including pieces by artists Angela Palmer and Junko Mori which help visitors to visualise the virus. Over 100 objects illustrate the response to curb its impact. Credit: Guy Bell
RF2E9DEB4–Different types of coronavirus or covid-19 vaccines. Illustration of mRNA, DNA, viral vector, spike protein and weakened or killed virus vaccines bein
RM2F1FTG2–Varese, Italy. 08th Mar, 2021. Varese, Italy ASST Sette Laghi Research procedure in the microbiology laboratory led by Prof. Fabrizio Maggi and his team during the reconstruction of the new virus genome with the sequencing of the entire instrumental of the entire spike protein, the part of Sars CoV- 2 In the photo: moments of the virus analysis and identification process Credit: Independent Photo Agency/Alamy Live News
RM2KWJ3Y0–London, England. 30.12.22. Genetic code for the virus that causes COVID-19, highlighted in pink is the sequence responsible for producing the spike protein at Injecting Hope: The race for a COVID-19 vaccine at the Science Museum. Injecting Hope opens today and explores the worldwide effort to develop vaccines at pandemic speed. Credit: SMP News / Alamy Live News
RM2DAF1FF–November 12, 2020, Kawasaki, Japan - This picture shows a logo of Japanese drug design venture PeptiDream at the company's headquarters in Kawasaki, suburban Tokyo on Thursday, November 12, 2020. PeptiDream announces the company will form a joint venture PeptiAID with four companies to development of the new drug for the treatment of COVID-19. PeptiDream developed PDPS technology to find peptide candidates targeting spike protein of coronavirus to enter human cells. PeptiAID will obtain PeptiDream's COVID-19 candidate compounds to enter clinical testing. (Photo by Yoshio Tsunoda/AFLO)
RF2J3CTK8–Abstract sphere image with spikes around and the sphere consisting of triangles. Communication or complexity concept.
RF2HH7858–Covid-19 seen under the microscope. Virus variant, coronavirus, spike protein. SARS-CoV-2, 3d rendering
RM2D4R708–3D print of a spike protein on the surface of SARS-CoV-2—also known as 2019-nCoV, the virus that causes COVID-19, spike proteins cover the surface of
RF2D381RR–Corona virus particle (SARS-CoV-2, Covid 19). An accurate and updated 3d model based on scientific structural data from the Protein Data Bank.
RM2KWGFT1–London, UK. 30th Nov, 2022. Museum staff pose with a visual presentation of the long genetic code of the virus, with the pink part representing the spike protein. Injecting Hope: The race for a COVID-19 vaccine explores the worldwide effort to develop vaccines at pandemic speed in a free exhibition at the Science Museum. It aims to make the invisible visible, from examining the virus itself to revealing the work that made the vaccines possible. Credit: Imageplotter/Alamy Live News
RF2FMNFCT–Corona virus symbolized by protective ffp2 face mask and rapid antigen self test kits as spike proteins placed on wooden surface
RM2GF7NRR–ExeVir. Bio BV Chief medical officer Dominique Tersago, Dr. Bert Schepens (VIB-UGent Center for Medical Biotechnology research), Dr. Xavier Saelens (VIB-UGent Center for Medical Biotechnology group leader) and Dr. Nico Callewaert (director of the VIB-UGent Center for Medical Biotechnology) show an enlarged 3D model of a spike protein (blue) connected to an antibody (red) in Ghent, Belgium August 23, 2021. REUTERS/ Bart Biesemans
RM2HTJ5A4–Bielefeld, Germany. 28th Feb, 2022. The Nuvaxovid vaccine is stored in a refrigerator at the pharmacy of the Bielefeld Vaccination Center. For a short time, the corona vaccine Nuvaxovid (NVX-CoV2373) from the US manufacturer Novavax has been vaccinated in Germany. Nuvaxovid is a so-called protein vaccine. It contains coronavirus-like particles with the corona protein 'spike protein'. Credit: Friso Gentsch/dpa/Alamy Live News
RM2KWG9X1–London, UK. 30 Nov 2022. Genetic code for the virus that causes COVID-19, highlighted in pink is the sequence responsible for producing the spike protein - Injecting Hope: The race for a COVID-19 vaccine, a new exhibition at the Science Museum. It explores the worldwide effort to develop vaccines. It aims make the invisible visible: from examining the virus itself to revealing the work that made the vaccines possible. Including pieces by artists Angela Palmer and Junko Mori which help visitors to visualise the virus. Over 100 objects illustrate the response to curb its impact. Credit: Guy Bell
RF2FN0XRY–Concepts of different types of covid-19 vaccine agaist coronavirus. Vaccines made from mRNA, viral vector, weaken virus and spike protein on chess boa
RM2F1FTFY–Varese, Italy. 08th Mar, 2021. Varese, Italy ASST Sette Laghi Research procedure in the microbiology laboratory led by Prof. Fabrizio Maggi and his team during the reconstruction of the new virus genome with the sequencing of the entire instrumental of the entire spike protein, the part of Sars CoV- 2 In the photo: moments of the virus analysis and identification process Credit: Independent Photo Agency/Alamy Live News
RM2KWJ3R8–London, England. 30.12.22. Genetic code for the virus that causes COVID-19, highlighted in pink is the sequence responsible for producing the spike protein at Injecting Hope: The race for a COVID-19 vaccine at the Science Museum. Injecting Hope opens today and explores the worldwide effort to develop vaccines at pandemic speed. Credit: SMP News / Alamy Live News
RM2DAF1GJ–Kawasaki, Japan. 12th Nov, 2020. Japan's drug design venture PeptiDream vice president Keiichi Masuya announces PeptiDream will form a joint venture PeptiAID with four companies to development of the new drug for the treatment of COVID-19 at the company's headquarters in Kawasaki, suburban Tokyo on Thursday, November 12, 2020. PeptiDream developed PDPS technology to find peptide candidates targeting spike protein of coronavirus to enter human cells. PeptiAID will obtain PeptiDream's COVID-19 candidate compounds to enter clinical testing. Credit: Yoshio Tsunoda/AFLO/Alamy Live News
RF2C5NWJ2–Molecular model of a coronavirus spike (S) protein (red) bound to an angiotensin-converting enzyme 2 (ACE2) receptor (blue) on a human cell.
RM2HP70P3–3D print of a coronavirus spike. The spike is a protein on the coronavirus surface that helps the virus enter and infect cells. ca. 2020
RF2HH859Y–Covid-19 seen under the microscope. Virus variant, coronavirus, spike protein. SARS-CoV-2, 3d rendering
RM2D4R71X–3D print of a spike protein on the surface of SARS-CoV-2—also known as 2019-nCoV, the virus that causes COVID-19, spike proteins cover the surface of
RF2CAH5EB–Structure of the SARS-CoV-2 spike glycoprotein, surface model, black background, 3D illustration isolated
RF2D381NW–Corona virus particle (SARS-CoV-2, Covid 19). An accurate and updated 3d model based on scientific structural data from the Protein Data Bank.
RF2BBKN2Y–Labelled diagram of COVID-19 cell structure showing spike glycoprotein, membrane protein, envelope, RNA. 3d illustration schematic of coronavirus.
RM2HTJ5A9–Bielefeld, Germany. 28th Feb, 2022. The Nuvaxovid vaccine is stored in a refrigerator at the pharmacy of the Bielefeld Vaccination Center. For a short time, the corona vaccine Nuvaxovid (NVX-CoV2373) from the US manufacturer Novavax has been vaccinated in Germany. Nuvaxovid is a so-called protein vaccine. It contains coronavirus-like particles with the corona protein 'spike protein'. Credit: Friso Gentsch/dpa/Alamy Live News
RM2KWGFJY–London, UK. 30 Nov 2022. Genetic code for the virus that causes COVID-19, highlighted in pink is the sequence responsible for producing the spike protein - Injecting Hope: The race for a COVID-19 vaccine, a new exhibition at the Science Museum. It explores the worldwide effort to develop vaccines. It aims make the invisible visible: from examining the virus itself to revealing the work that made the vaccines possible. Including pieces by artists Angela Palmer and Junko Mori which help visitors to visualise the virus. Over 100 objects illustrate the response to curb its impact. Credit: Guy Bell
RF2B3RKRK–3D structure of the 2019-nCoV coronavirus spike, a target for vaccine against Covid-19. PDB 6VSB
RM2F1FTFT–Varese, Italy. 08th Mar, 2021. Varese, Italy ASST Sette Laghi Research procedure in the microbiology laboratory led by Prof. Fabrizio Maggi and his team during the reconstruction of the new virus genome with the sequencing of the entire instrumental of the entire spike protein, the part of the Sars CoV- 2 In the photo: Prof. Fabrizio Maggi Credit: Independent Photo Agency/Alamy Live News
RM2KWJ3HP–London, England. 30.12.22. Genetic code for the virus that causes COVID-19, highlighted in pink is the sequence responsible for producing the spike protein at Injecting Hope: The race for a COVID-19 vaccine at the Science Museum. Injecting Hope opens today and explores the worldwide effort to develop vaccines at pandemic speed. Credit: SMP News / Alamy Live News
RM2DAF1FJ–Kawasaki, Japan. 12th Nov, 2020. Japan's drug design venture PeptiDream vice president Keiichi Masuya (L) smiles with executives from Fujitsu, Mizuho Capital, Takenaka Corp and Lishida Chmical as he announces PeptiDream will form a joint venture PeptiAID with four companies to development of the new drug for the treatment of COVID-19 at the company's headquarters in Kawasaki, suburban Tokyo on Thursday, November 12, 2020. PeptiDream developed PDPS technology to find peptide candidates targeting spike protein of coronavirus to enter human cells. PeptiAID will obtain PeptiDream's COVID-19 c
RM2HB9ER4–Omicron Covid-19 coronavirus virus particle - concept image made with circle of positive lateral flow test strip protein spikes around a sphere
RF2E98B8N–A mutating Virus that causes Coronavirus COVID-19. A virus with changing protein spikes. 3D illustration render.
RF2HGK6JW–Covid-19 seen under the microscope. Virus variant, coronavirus, spike protein. SARS-CoV-2, 3d rendering
RM2D4R71J–3D print of a spike protein on the surface of SARS-CoV-2—also known as 2019-nCoV, the virus that causes COVID-19, spike proteins cover the surface of
RF2CAH5EC–Structure of the SARS-CoV-2 spike glycoprotein, surface model, white background, 3D illustration isolated
RF2D381N5–Corona virus particle (SARS-CoV-2, Covid 19). An accurate and updated 3d model based on scientific structural data from the Protein Data Bank.
RF2BE6KY6–Accurate scientific render of a coronavirus cell like covid or a flu virus structure with spikes glycoprotein, M proteins, E proteins, hemagglutinin a
RM2HTJ5A8–Bielefeld, Germany. 28th Feb, 2022. A syringe with the vaccine Nuvaxovid is drawn up in the pharmacy by the Impfzentrum Bielefeld. The corona vaccine Nuvaxovid (NVX-CoV2373) from the US manufacturer Novavax has been vaccinated in Germany for a short time. Nuvaxovid is a so-called protein vaccine. It contains coronavirus-like particles with the corona protein 'spike protein'. Credit: Friso Gentsch/dpa/Alamy Live News
RM2KWG9WK–London, UK. 30 Nov 2022. Genetic code for the virus that causes COVID-19, highlighted in pink is the sequence responsible for producing the spike protein - Injecting Hope: The race for a COVID-19 vaccine, a new exhibition at the Science Museum. It explores the worldwide effort to develop vaccines. It aims make the invisible visible: from examining the virus itself to revealing the work that made the vaccines possible. Including pieces by artists Angela Palmer and Junko Mori which help visitors to visualise the virus. Over 100 objects illustrate the response to curb its impact. Credit: Guy Bell
RF2B3RKD3–3D structure of the 2019-nCoV coronavirus spike, a target for vaccine against Covid-19. PDB 6VSB
RM2F1FTM9–Varese, Italy. 08th Mar, 2021. Varese, Italy ASST Sette Laghi Research procedure in the microbiology laboratory led by Prof. Fabrizio Maggi and his team during the reconstruction of the new virus genome with the sequencing of the entire instrumental of the entire spike protein, the part of the Sars CoV- 2 In the photo: Prof. Fabrizio Maggi Credit: Independent Photo Agency/Alamy Live News
RM2KWJ3MK–London, England. 30.12.22. Genetic code for the virus that causes COVID-19, highlighted in pink is the sequence responsible for producing the spike protein at Injecting Hope: The race for a COVID-19 vaccine at the Science Museum. Injecting Hope opens today and explores the worldwide effort to develop vaccines at pandemic speed. Credit: SMP News / Alamy Live News
RM2DAF1G6–Kawasaki, Japan. 12th Nov, 2020. Japan's drug design venture PeptiDream vice president Keiichi Masuya announces PeptiDream will form a joint venture PeptiAID with four companies to development of the new drug for the treatment of COVID-19 at the company's headquarters in Kawasaki, suburban Tokyo on Thursday, November 12, 2020. PeptiDream developed PDPS technology to find peptide candidates targeting spike protein of coronavirus to enter human cells. PeptiAID will obtain PeptiDream's COVID-19 candidate compounds to enter clinical testing. Credit: Yoshio Tsunoda/AFLO/Alamy Live News
RM2HB9ER5–Omicron Covid-19 coronavirus virus particle - concept image made with circle of positive lateral flow test strip protein spikes around a sphere
RF2HE5NMT–COVID-19 Corona virus with spike glycoprotein are floating on the air . Blue color background . 3D rendering .
Search Results for Spike protein Stock Photos and Images (1,810)
Page 1 of 19